Awak Technologies, a Singapore-based medical technology company, raised over USD$20M in Series B funding.
The round was led by Lion X Ventures and Vickers Venture Partners, with participation from Advanced MedTech and Eckuity Capital.
The company intends to use the funds to complete the ongoing human pre-pivotal clinical trial, further enhance the products and portfolio, and get closer to a US-based pivotal trial before launching in the US market.
Led by CEO Suresha Venkataraya, Awak Technologies is a patient-centric medical technology company whose ultra-portable peritoneal dialysis system enables kidney disease patients to undergo dialysis at home as well as anywhere on the go. Its patented technologies regenerate and reconstitute waste dialysis fluid into usable fluid thus reducing the amount of dialysis fluid needed by up to 90 per cent and enable the miniaturisation of the dialysis machine to fit into a small carry bag.
The company has offices in Burbank, California, USA and Bengaluru, India.
FinSMEs
13/09/2023